Diagnosis and assessment of pulmonary arterial hypertension.
暂无分享,去创建一个
Horst Olschewski | Adam Torbicki | A. Torbicki | D. Badesch | R. Naeije | J. Loyd | M. Hoeper | H. Olschewski | R. Oudiz | H. Champion | A. Manes | Robert Naeije | Marius M Hoeper | Alessandra Manes | David B Badesch | Miguel Angel Gomez Sanchez | Hunter C Champion | James E Loyd | Michael McGoon | Ronald J Oudiz | M. Sánchez | M. Mcgoon
[1] B. Hamm,et al. Comparison of Electron Beam Computed Tomography With Magnetic Resonance Imaging in Assessment of Right Ventricular Volumes and Function , 2004, Journal of computer assisted tomography.
[2] V. Fuster,et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.
[3] M. Humbert,et al. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. , 2010, European heart journal.
[4] R. Naeije,et al. Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. , 2005, American journal of physiology. Heart and circulatory physiology.
[5] J. Parker,et al. A hemodynamic study of acute coronary insufficiency precipitated by exercise. With observations on the effects of nitroglycerin. , 1966, The American journal of cardiology.
[6] R. Coleman,et al. Regulation of Stroke Volume during Submaximal and Maximal Upright Exercise in Normal Man , 1986, Circulation research.
[7] D. Mccrory,et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[8] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[9] W. H. Herbert,et al. Pulmonary circulation in the aged. , 1967, Journal of applied physiology.
[10] W. Hildebrandt,et al. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. , 2000, Journal of the American College of Cardiology.
[11] K. Hossack,et al. Atrial natriuretic factor production during upright exercise. , 1990, Cardiology.
[12] Horst Olschewski,et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. , 2004, European heart journal.
[13] O. Castro,et al. Pulmonary hypertension in sickle cell disease. , 2011, The American journal of cardiology.
[14] J. Bronzwaer,et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.
[15] J. Rivier,et al. [Exercise test and cardiac catheterization]. , 1957, Cardiologia.
[16] M. Humbert,et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. , 2005, Arthritis and rheumatism.
[17] A. Jánosi,et al. Pulmonary artery pressure and oxygen consumption measurement during supine bicycle exercise. , 1988, Chest.
[18] M. Pillinger,et al. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension , 2006 .
[19] E. Trulock,et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[20] R. Souza,et al. [Clinical characteristics of pulmonary hypertension patients in two reference centers in the city of Sao Paulo]. , 2006, Revista da Associacao Medica Brasileira.
[21] D. Badesch,et al. Ambrisentan therapy for pulmonary arterial hypertension. , 2005, Journal of the American College of Cardiology.
[22] S. Rich,et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.
[23] R. Speich,et al. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. , 1997, American journal of respiratory and critical care medicine.
[24] A. Branzi,et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension , 2008, European heart journal.
[25] Horst Olschewski,et al. Magnetic Resonance–Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial Pressure , 2008, Circulation. Cardiovascular imaging.
[26] Boxt Lm. MR imaging of pulmonary hypertension and right ventricular dysfunction. , 1996 .
[27] K. Hossack,et al. Maximal cardiac output during upright exercise: approximate normal standards and variations with coronary heart disease. , 1980, The American journal of cardiology.
[28] J. Widimský,et al. The Effect of Age on the Pressure-flow Relationship and on the Capacity of the Pulmonary Vascular Bed with Special Reference to the Condition of High Flow , 1970 .
[29] J. Sandoval,et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.
[30] L. Ekelund,et al. Circulatory and Respiratory Adaptation, during Long‐Term, Non‐Steady State Exercise, in the Sitting Position1 , 1964 .
[31] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[32] E. Braunwald,et al. Characterization of the Circulatory Response to Maximal Upright Exercise in Normal Subjects and Patients with Heart Disease , 1967, Circulation.
[33] V. Perifanis,et al. Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. , 2004, Haematologica.
[34] J. Bronzwaer,et al. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. , 2007, Chest.
[35] P. Light,et al. Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility , 2007, Circulation.
[36] B. Groves,et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.
[37] N. Rajagopalan,et al. Tricuspid Annular Systolic Velocity: A Useful Measurement in Determining Right Ventricular Systolic Function Regardless of Pulmonary Artery Pressures , 2006, Echocardiography.
[38] J. Hickam,et al. EFFECT OF EXERCISE ON CARDIAC OUTPUT AND PULMONARY ARTERIAL PRESSURE IN NORMAL PERSONS AND IN PATIENTS WITH CARDIOVASCULAR DISEASE AND PULMONARY EMPHYSEMA. , 1948, The Journal of clinical investigation.
[39] A. Esterman,et al. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation , 2006, Internal medicine journal.
[40] G. Koch,et al. Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension , 1997 .
[41] R. Dore,et al. Pulmonary hypertension: role of computed tomography and magnetic resonance imaging. , 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.
[42] S. Kimmel,et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. , 2003, Chest.
[43] K. Rühle,et al. [Hemodynamics, plasma catecholamine behavior and beta-adrenergic receptor density in trained and untrained subjects and cardiac insufficiency patients]. , 1983, Zeitschrift fur Kardiologie.
[44] H. Gurtner,et al. [The hemodynamics of healthy students at rest and under graduated work load]. , 1967, Medicina thoracalis.
[45] K. Donald,et al. The effect of exercise on the cardiac output and circulatory dynamics of normal subjects. , 1955, Clinical science.
[46] A. Holmgren,et al. CIRCULATORY AND RESPIRATORY ADAPTATION, DURING LONG-TERM, NON-STEADY STATE EXERCISE, IN THE SITTING POSITION. , 1964, Acta physiologica Scandinavica.
[47] K. Kangawa,et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.
[48] G. Simonneau,et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. , 2008, American journal of respiratory and critical care medicine.
[49] K. G. Balakrishnan,et al. Primary pulmonary hypertension: natural history and prognostic factors. , 1994, Indian heart journal.
[50] A. Torbicki,et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. , 2006, Chest.
[51] Avid,et al. BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION , 2002 .
[52] A. Hadengue,et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. , 1991, Gastroenterology.
[53] Paolo Prandoni,et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.
[54] A. Fishman,et al. Effects of Acute Hypoxia and Exercise on the Pulmonary Circulation , 1960, Circulation.
[55] G. Gaul,et al. Comparison of supine and sitting body position during a triangular exercise test , 1977, European Journal of Applied Physiology and Occupational Physiology.
[56] R. Riley,et al. Studies of the pulmonary circulation at rest and during exercise in normal individuals and in patients with chronic pulmonary disease. , 1948, The American journal of physiology.
[57] H. Zwick,et al. [The normal range of the pulmonary artery pressure during ergometrical exercise (author's transl)]. , 1976, Medizinische Klinik.
[58] M. Remy-Jardin,et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. , 2007, The Journal of rheumatology.
[59] S. Doutreleau,et al. Pulmonary hemodynamics during a strenuous intermittent exercise in healthy subjects. , 2003, Medicine and science in sports and exercise.
[60] S. Kimmel,et al. Hemodynamics and survival of patients with portopulmonary hypertension , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[61] T. Welte,et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension , 2005, European Respiratory Journal.
[62] A. Shillington,et al. Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.
[63] T. Ueland,et al. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. , 2006, The American journal of cardiology.
[64] A Berghold,et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review , 2009, European Respiratory Journal.
[65] T. Strandell,et al. RELATIONSHIPS BETWEEN CARDIAC OUTPUT, STROKE VOLUME AND INTRACARDIAC PRESSURES AT REST AND DURING EXERCISE IN SUPINE POSITION AND SOME ANTHROPOMETRIC DATA IN HEALTHY OLD MEN. , 2009, Acta medica Scandinavica.
[66] A. Lahad,et al. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease , 1998, The Lancet.
[67] L. Hartley,et al. Reduction of stroke volume during exercise in man following ascent to 3,100 m altitude. , 1967, Journal of applied physiology.
[68] R. Barst,et al. Survival with first-line bosentan in patients with primary pulmonary hypertension , 2005, European Respiratory Journal.
[69] E. Paganini,et al. Refractory congestive heart failure: overview and application of extracorporeal ultrafiltration. , 1996, Advances in renal replacement therapy.
[70] M. Humbert,et al. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. , 2006, European heart journal.
[71] T SJOSTRAND,et al. Circulatory data in normal subjects at rest and during exercise in recumbent position, with special reference to the stroke volume at different work intensities. , 1960, Acta physiologica Scandinavica.
[72] W. Laskey,et al. Right ventricular-pulmonary arterial interactions , 2006, Annals of Biomedical Engineering.
[73] M. Oberholzer,et al. Influence of age on pulmonary haemodynamics at rest and during supine exercise. , 1983, Clinical science.
[74] M. Mcgoon,et al. The assessment of pulmonary hypertension. , 2001, Clinics in chest medicine.
[75] M. Mehra,et al. Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. , 2004, Congestive heart failure.
[76] F. Loogen,et al. [Hemodynamics of the pulmonary circulation during a multistep exercise test in healthy subjects]. , 1976, Die Medizinische Welt.
[77] H. Denolin,et al. Normal pulmonary pressure-flow relationship during exercise in the sitting position , 2004, Internationale Zeitschrift für angewandte Physiologie einschließlich Arbeitsphysiologie.
[78] C. Lavie,et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. , 2002, Circulation.
[79] D. Mccrory,et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[80] T. Abraham,et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.
[81] J. S. Bower,et al. Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension. , 1984, The American review of respiratory disease.
[82] M. Humbert,et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol , 2005, Thorax.
[83] A HOLMGREN,et al. Circulatory studies in well trained athletes at rest and during heavy exercise. With special reference to stroke volume and the influence of body position. , 1963, Acta physiologica Scandinavica.
[84] D. Mccrory,et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[85] T. Kuriyama,et al. Prediction of life expectancy in patients with primary pulmonary hypertension. A retrospective nationwide survey from 1980-1990. , 1999, Internal medicine.
[86] D A Redelmeier,et al. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.
[87] C S Houston,et al. Operation Everest II: preservation of cardiac function at extreme altitude. , 1987, Journal of applied physiology.
[88] M. Gladwin,et al. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension , 2005, British journal of haematology.
[89] A J Tajik,et al. Doppler echocardiographic index for assessment of global right ventricular function. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[90] R. Barst,et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. , 2006, Journal of the American College of Cardiology.
[91] B. Zilberstein,et al. Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis--prospective study. , 2003, Hepato-gastroenterology.
[92] W. Ageno,et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. , 2006, Chest.
[93] C. Denton,et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. , 2006, European heart journal.
[94] Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.
[95] A. Damato,et al. Hemodynamic response to treadmill exercise in normal subjects. , 1966, Journal of applied physiology.
[96] J. Widimský,et al. EFFECT OF REPEATED EXERCISE ON THE LESSER CIRCULATION. , 1963, Journal of applied physiology.
[97] C. Higgins,et al. Evaluation of the right ventricle by magnetic resonance imaging. , 1987, American heart journal.
[98] P. Arbogast,et al. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. , 2003, American journal of respiratory and critical care medicine.
[99] E. Robin,et al. PRIMARY PULMONARY HYPERTENSION , 2022 .
[100] C. Fischer,et al. Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene , 2000, Circulation.
[101] B. Groves,et al. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. , 1987, Journal of applied physiology.
[102] G. Simonneau,et al. EFFECTS OF THE DUAL ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN IN PATIENTS WITH PULM HT: A RANDOMIZED PLACEBO CONTROLLED STUDY , 2001 .
[103] M. Humbert,et al. Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia , 2009, Circulation.
[104] S. Inzucchi,et al. Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by (131)I treatment. , 1999, Chest.
[105] L. Ekelund,et al. Circulatory and Respiratory Adaptation during Prolonged Exercise in the Supine Position , 1966 .
[106] R. Naeije,et al. Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension. , 2004, Chest.
[107] Gilles Garcia,et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.
[108] Jeffrey L. Anderson,et al. ACCF/AHA Expert Conseusus Document , 2009 .
[109] J. Widimský,et al. Central haemodynamics during supine exercise and pulmonary artery occlusion in normal subjects. , 1973, Bulletin de physio-pathologie respiratoire.
[110] M N Sawka,et al. Central hemodynamics during progressive upper- and lower-body exercise and recovery. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.
[111] J. Mlczoch,et al. [Pulmonary circulation as a limiting factor in physical work capacity (author's transl)]. , 1976, Pneumonologie. Pneumonology.
[112] V. Fuster. Hurst's the Heart , 1966 .
[113] A. Bardají,et al. Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. , 2005, The American journal of medicine.
[114] L. Dexter,et al. Effect of exercise on circulatory dynamics of normal individuals. , 1951, Journal of applied physiology.
[115] B. Brundage,et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. , 1997, Journal of the American College of Cardiology.
[116] Stuart Rich,et al. Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.
[117] H. Tan,et al. A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. , 2007, European heart journal.
[118] L. Boxt. MR imaging of pulmonary hypertension and right ventricular dysfunction. , 1996, Magnetic resonance imaging clinics of North America.
[119] M. Yacoub,et al. Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. , 1994, British heart journal.
[120] L. Boxt,et al. Magnetic Resonance Imaging for Quantitation of Right Ventricular Volume in Patients with Pulmonary Hypertension , 1993, Journal of thoracic imaging.
[121] M F O'Rourke,et al. Vascular impedance in studies of arterial and cardiac function. , 1982, Physiological reviews.
[122] M. Humbert,et al. Splenectomy and chronic thromboembolic pulmonary hypertension , 2005, Thorax.
[123] N. Dean,et al. Noninvasive Evaluation of Pulmonary Artery Pressure During Exercise by Saline-Enhanced Doppler Echocardiography in Chronic Pulmonary Disease , 1989, Circulation.
[124] M. Schemper,et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension , 2005, Thrombosis and Haemostasis.
[125] T. Medsger,et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. , 1986, Arthritis and rheumatism.
[126] G. Kane. Primary pulmonary hypertension in HIV infection. , 1992, Chest.
[127] L N KATZ,et al. Effect of training on response of cardiac output to muscular exercise in athletes. , 1955, Journal of applied physiology.
[128] P. Flemming,et al. Pulmonary Hypertension after Splenectomy? , 1999, Annals of Internal Medicine.
[129] H. Denolin,et al. The Effect of Age on Pulmonary Circulation in Normal Subjects , 1970 .
[130] A. DeMaria,et al. Noninvasive assessment of pulmonary vascular resistance using Doppler tissue imaging of the tricuspid annulus. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[131] D. Pennell,et al. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. , 2005, American journal of respiratory and critical care medicine.
[132] A. Cohen-Solal,et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study , 2003, Hepatology.
[133] R. Naeije,et al. Reflections on wave reflections in chronic thromboembolic pulmonary hypertension. , 2007, European heart journal.
[134] C. Hernández,et al. [Cardiovascular manifestations in progressive systemic sclerosis]. , 1985, Archivos del Instituto de Cardiologia de Mexico.
[135] V. Perifanis,et al. Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. , 2004, Haematologica.
[136] L. Rubin,et al. Primary pulmonary hypertension , 1998, The Lancet.
[137] J. Parker,et al. Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. , 1978, The American journal of cardiology.
[138] H. Kreisman,et al. Evaluation of right ventricular systolic pressure during incremental exercise by Doppler echocardiography in adults with atrial septal defect. , 1998, Chest.
[139] R. Naeije,et al. Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? , 2007, European Respiratory Journal.
[140] G. Koch,et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.
[141] M. Morpurgo,et al. Pulmonary input impedance or pulmonary vascular resistance? , 1995, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[142] T. Kunieda. Primary pulmonary hypertension and its life prognosis. , 1999, Internal medicine.
[143] J. Lamounier,et al. Pulmonary hypertension in schistosomiasis mansoni. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[144] G E Gale,et al. Pulmonary gas exchange in humans exercising at sea level and simulated altitude. , 1986, Journal of applied physiology.
[145] J B Seward,et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.
[146] D. Gibson,et al. Left ventricular filling characteristics in pulmonary hypertension: a new mode of ventricular interaction , 1992, British heart journal.
[147] O. Balchum,et al. The effect of mild exercise in the supine position on the pulmonary arterial pressure of five normal human subjects. , 1954, The Journal of clinical investigation.
[148] M. Böhm,et al. Current Therapy of Pulmonary Hypertension , 2005, Herz Kardiovaskuläre Erkrankungen.
[149] R. Delsignore,et al. Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. , 2006, European journal of internal medicine.
[150] D. Badesch,et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. , 2007, Chest.
[151] R. Wiesner,et al. Portopulmonary hypertension: Results from a 10‐year screening algorithm , 2006, Hepatology.
[152] Maurizio Marvisi,et al. Distiroidismi e ipertensione polmonare , 2004 .
[153] M. Yigla,et al. Primary pulmonary hypertension in Israel: a national survey. , 2001, Chest.
[155] Orris,et al. INHALED ILOPROST FOR SEVERE PULMONARY HYPERTENSION , 2002 .
[156] D. Badesch,et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.
[157] M. Baron,et al. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. , 2005, The Journal of rheumatology.
[158] N. Banchero,et al. Pulmonary Pressure, Cardiac Output, and Arterial Oxygen Saturation during Exercise at High Altitude and at Sea Level , 1966, Circulation.
[159] J. Bishop,et al. The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis. , 1968, Cardiovascular research.
[160] A HOLMGREN,et al. The effect of body position on the circulation at rest and during exercise, with special reference to the influence on the stroke volume. , 1960, Acta physiologica Scandinavica.
[161] B JONSSON,et al. CIRCULATION IN HEALTHY OLD MEN, STUDIED BY RIGHT HEART CATHETERIZATION AT REST AND DURING EXERCISE IN SUPINE AND SITTING POSITION. , 2009, Acta medica Scandinavica.
[162] D. James,et al. Distensibility Characteristics of the Human Pulmonary Vascular Bed: Study of the Pressure‐Volume Response to Exercise in Patients with and without Heart Disease , 1967, Circulation.
[163] J. Oh,et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[164] M. Fontana,et al. Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes , 2007, British journal of pharmacology.
[165] L. Boxt,et al. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. , 1992, Journal of the American College of Cardiology.
[166] W. Chung,et al. [Genetics and genomics of pulmonary arterial hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[167] L. Rakita,et al. Response of pulmonary artery pressure and total pulmonary resistance of untrained, convalescent man to prolonged mild steady state exercise. , 1957, The Journal of clinical investigation.
[168] N. Reichek,et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. , 1989, Circulation.
[169] R. Hetzer,et al. Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing , 2002, Circulation.
[170] R. Redberg,et al. Abnormal pulmonary artery pressure profile after cardiac transplantation: an exercise Doppler echocardiographic study. , 1995, American heart journal.
[171] J. Lima,et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). , 2005, Arthritis and rheumatism.
[172] M. Humbert,et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.
[173] R. Naeije,et al. False-positive diagnosis of pulmonary hypertension by Doppler echocardiography. , 1998, European Respiratory Journal.
[174] H. Piene. Pulmonary arterial impedance and right ventricular function. , 1986, Physiological reviews.
[175] G. Koch,et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. , 1999, The American journal of cardiology.
[176] K. Lewis. Pulmonary Arterial Hypertension in France: Results from a National Registry , 2007 .
[177] M. Fujita,et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.
[178] R. Naeije,et al. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. , 2007, American journal of respiratory and critical care medicine.
[179] R. Naeije,et al. High-Altitude–Induced Right-Heart Failure , 2007 .
[180] B. Wiens,et al. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2 , 2008, Circulation.
[181] P. Walser,et al. Normal Values for Pulmonary Hemodynamics at Rest and during Exercise in Man , 1975 .
[182] L. Jorfeldt,et al. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. , 1999, Circulation.